advertising and marketing costs very high at over $1m for Q3. Hoping that is a one off of sorts in order to get rhinoswab out there. If they can reduce that down to $250/quarter then RNO is in profit.
- Forums
- ASX - By Stock
- RNO
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-5
Featured News
Add RNO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online